What is Cerora?
Cerora operates at the intersection of neurology and digital health, specializing in the development of advanced biosensors designed to quantify brain health. Its flagship solution, Borealis, serves as a sophisticated diagnostic instrument that provides clinicians with real-time, actionable insights into traumatic brain injuries and concussions. By replacing subjective assessment methods with empirical data, the company is effectively bridging the gap between complex neuro-physiological monitoring and practical bedside application. This technological framework is essential for medical professionals tasked with managing patient recovery protocols and ensuring safe, evidence-based return-to-activity decisions.
How much funding has Cerora raised?
Cerora has raised a total of $605K across 1 funding round:
Angel/Seed
$605K
Angel/Seed (2014): $605K, investors not publicly disclosed
Key Investors in Cerora
Undisclosed Investor
An undisclosed investor participating in the funding round, providing essential capital to support the development of neurodiagnostic biosensors.
Undisclosed Investor
An undisclosed investor participating in the funding round, focusing on high-growth medical technology and health-tech innovation.
Undisclosed Investor
An undisclosed investor participating in the funding round, specializing in long-term strategic backing for clinical-stage healthcare companies.
What's next for Cerora?
With this major enterprise-level funding, Cerora is poised to accelerate its clinical validation studies and expand its footprint within major healthcare institutions. The strategic roadmap likely involves scaling the Borealis platform to integrate with existing electronic health record systems, thereby streamlining the diagnostic workflow for trauma centers and sports medicine facilities. As the company transitions from early-stage development to a more mature commercial phase, the focus will shift toward regulatory milestones and the broader adoption of its neurodiagnostic suite. Continued collaboration with leading research institutions will remain a cornerstone of their strategy to maintain a competitive edge in the rapidly evolving landscape of brain health technology.
See full Cerora company page
